And here I heard Dew that Bavi was just a placebo and would never make it to Phase III. Guess the yardstick got moved down the field huh. Before Bavi didn't work at all and now it is enrollment numbers aren't given out. I'm told enrollment is on track for completion by the end of this year.
After the dose switching debacle I'm surprised management has even said this much. What's next management picked a poor name for the trial. And tell me again DEW what phase was that OCRX trial in?